Watchlist Price Alert

CRISPR Therapeutics AG (CRSP)

NASDAQ: CRSP · Real-Time Price · USD

45.02

3.44 (8.27%)

At close: Jun 17, 2025, 10:52 AM

CRISPR Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	298.26M	389.48M	211.88M	923.03M	1.17B	943.77M	456.65M	239.76M	315.52M
Short-Term Investments	1.61B	1.3B	1.6B	1.46B	521.71M	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	1.97M	53.13M	16.91M	16.85M	5.04M	3.16M	3.15M	3.15M
Other Long-Term Assets	27.35M	13.57M	16.27M	22.2M	18.14M	6.14M	3.83M	3.76M	3.35M
Receivables	25M	200M	n/a	305K	144K	99K	88K	2.63M	3.16M
Inventory	n/a	n/a	-11.2M	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	8.31M	14.39M	37.71M	n/a	n/a	n/a	9.66M	6M	1.51M
Total Current Assets	1.94B	1.91B	1.85B	2.42B	1.72B	987.55M	466.39M	248.38M	320.19M
Property-Plant & Equipment	277.55M	305.94M	320.56M	312.04M	93.03M	72.83M	18.5M	18.86M	21.03M
Goodwill & Intangibles	n/a	16K	71K	125K	180K	235K	289K	344K	399K
Total Long-Term Assets	304.9M	321.49M	390.03M	334.36M	111.35M	79.2M	22.62M	22.96M	24.77M
Total Assets	2.24B	2.23B	2.24B	2.75B	1.83B	1.07B	489.02M	271.35M	344.96M
Account Payables	14.71M	38.15M	27.43M	14.82M	9.09M	5.94M	5.07M	1.64M	4.57M
Deferred Revenue	3.85M	4.11M	12.32M	1.01M	2.34M	960K	57.78M	56.93M	77.65M
Short-Term Debt	17.29M	27.99M	15.84M	12.16M	11.36M	8.49M	n/a	n/a	n/a
Other Current Liabilities	51.94M	33.13M	42.62M	55.35M	37.7M	17.41M	4.31M	2.01M	9.56M
Total Current Liabilities	87.78M	108.79M	121.11M	119.88M	94.26M	57.11M	27.75M	14.51M	22M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	3.44M	958K	5.97M	7.34M	7.63M	14.39M	11.29M	12.07M	12.47M
Total Long-Term Liabilities	222.17M	237.98M	246.47M	232.53M	69.47M	70.22M	69.08M	69M	90.12M
Total Liabilities	309.95M	346.77M	367.58M	352.42M	163.73M	127.33M	96.82M	83.51M	112.12M
Total Debt	223.69M	238.63M	244.02M	225.03M	61.43M	52.54M	n/a	n/a	n/a
Common Stock	2.7M	2.5M	2.44M	2.39M	2.28M	1.85M	1.58M	1.24M	1.22M
Retained Earnings	-1.37B	-999.7M	-846.09M	-195.91M	-573.58M	-224.71M	-291.57M	-125.44M	-57.08M
Comprehensive Income	1.84M	1.91M	-15.65M	-5.07M	-83K	7K	-8K	14K	-26K
Shareholders Equity	1.93B	1.88B	1.88B	2.4B	1.66B	939.42M	392.19M	187.83M	232.85M
Total Investments	1.61B	1.31B	1.66B	1.46B	521.71M	5.04M	3.16M	3.15M	3.15M